| 000 | 01669 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515132035.0 | ||
| 264 | 0 | _c20081022 | |
| 008 | 200810s 0 0 eng d | ||
| 022 | _a1473-5571 | ||
| 024 | 7 |
_a10.1097/QAD.0b013e328307f24a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDelaugerre, Constance | |
| 245 | 0 | 0 |
_aPattern and impact of emerging resistance mutations in treatment experienced patients failing darunavir-containing regimen. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cSep 2008 |
||
| 300 |
_a1809-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 | _aDarunavir |
| 650 | 0 | 4 |
_aDrug Resistance, Viral _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aHIV-1 _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPyridines _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrones _xtherapeutic use |
| 650 | 0 | 4 |
_aSulfonamides _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aPavie, Juliette | |
| 700 | 1 | _aPalmer, Pierre | |
| 700 | 1 | _aGhosn, Jade | |
| 700 | 1 | _aBlanche, Stephane | |
| 700 | 1 | _aRoudiere, Laurent | |
| 700 | 1 | _aDominguez, Stephanie | |
| 700 | 1 | _aMortier, Emmanuel | |
| 700 | 1 | _aMolina, Jean-Michel | |
| 700 | 1 | _ade Truchis, Pierre | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 22 _gno. 14 _gp. 1809-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/QAD.0b013e328307f24a _zAvailable from publisher's website |
| 999 |
_c18164543 _d18164543 |
||